Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200062899Phase 4Not yet recruiting
Phase 4, open-label trial of ciprofol and propofol in None (2 arms), sponsored by The First People's Hospital of Jingzhou. Primary endpoint: Overall incidence of adverse events. Planned start Aug 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200062899.